|
Mayo clinic implementation_RA |
Rheumatoid Arthritis (RA) |
Mayo Clinic |
Case, Control |
|
|
|
|
|
RA for NU GWAS population |
Rheumatoid Arthritis (RA) |
Northwestern University |
Case, Control |
96 |
3,987 |
|
|
|
KPWHRI RA |
Rheumatoid Arthritis (RA) |
KPWHRI |
Case, Control |
74 |
6,737 |
|
|
|
Geisinger Implementation |
Rheumatoid Arthritis (RA) |
Geisinger |
Case, Control |
351 |
12,402 |
|
|
|
KPWHRI RA revised 03jan2018 |
Rheumatoid Arthritis (RA) |
KPWHRI |
Case, Control |
74 |
6,737 |
|
|
|
RA_Columbia |
Rheumatoid Arthritis (RA) |
Columbia University |
Case, Control |
8 |
2,793 |
|
|
|
RA for NU eMERGEseq only population |
Rheumatoid Arthritis (RA) |
Northwestern University |
Case, Control |
|
|
|
|
|
CHOP NAFLD |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
CHOP |
Case Only |
12 |
|
100% |
|
|
Implementation of NAFLD by VUMC |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
VUMC |
Case, Control |
677 |
15,878 |
|
|
|
Geisinger Implementation |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
Geisinger |
Case, Control |
548 |
10,331 |
|
|
|
Harvard_NAFLD_Implementation |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
|
Case, Control |
453 |
9,273 |
|
|
|
NAFLD Implementation_Columbia |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
Columbia University |
Case, Control |
24 |
4,371 |
|
|
|
Marshfield NAFLD Implementation |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
|
Case Only |
|
|
|
|
|
NAFLD_Mayo clinic implementation |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
Mayo Clinic |
Case, Control |
|
|
|
|
|
NAFLD KPWA |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
KPWA/UW |
Case, Control |
383 |
5,236 |
|
|
|
NU NAFLD implementation |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
Northwestern University |
Case, Control |
57 |
|
|
|
|
Implementation for NAFLD |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
CCHMC |
Case Only |
|
|
89% |
100% |
|
NU FH implementation |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Northwestern University |
Case, Control |
|
|
|
|
|
AFH Implementation Columbia (updated) |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Columbia University |
Case, Control |
|
|
|
|
|
NU FH 2018 with chart reviewed family hx and NLP for FH sx |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Northwestern University |
Case Only |
|
|
|
|
|
Geisinger eMERGE-Seq Implementation |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Geisinger |
Case, Control |
|
|
|
|
|
Mayo FH Implementation |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Mayo Clinic |
Case, Control |
58 |
42 |
100%, 98% |
100%, 100% |
|
Implementation For Phase 3 eMERGE |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Geisinger |
Case, Control |
25 |
25 |
100%, 96% |
|
|
Vanderbilt Implementation |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
|
Case, Control |
153 |
2,152 |
|
|
|
Harvard - Adult Familial Hypercholesterolemia |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Partners Healthcare |
Case, Control |
94 |
990 |
|
|
